Evaluation of surrogate matrices for standard curve preparation in tissue bioanalysis
Abstract
Background: The aim of this work was to investigate the feasibility of using tissue surrogate matrices and plasma for determining drug concentrations in tissues by LC–MS/MS. Results: The similarity of tissues was evaluated using eight model compounds with different SlogP values. For plasma dilution, the overall matrix effects of tissue samples were found to approximate to those of pure plasma samples when plasma percentage was increased. When a ten-fold plasma dilution was applied, the differences between the instrumental responses of diluted tissue samples and pure plasma samples with the same spiked concentrations were within ±20%. The results of tissue bioanalysis using plasma dilution and plasma curve for in vivo studies were acceptable with an averaged deviation of ±20–25% compared with data using traditional tissue curves. Conclusion: Results demonstrate that tissue samples can be quantified using surrogate matrices. Plasma standard curves can be used for quantitation of both plasma and plasma-diluted tissue samples.
References
- 1 ICH: Guideline for Industry. Pharmacokinetics: Guidance for repeated dose tissue distribution studies. Federal Register 60(40),11274–11275 (1995).
- 2 Yu C, Cohen L. Tissue sample preparation: not the same old grind. LC GC21,1038–1048 (2003).
- 3 Drummer OH. Requirements for bioanalytical procedures in postmortem toxicology. Anal. Bioanal. Chem.388(7),1495–1503 (2007).
- 4 Blasco C, Di Corcia A, Pico Y. Determination of tetracyclines in multi-species animal tissues by pressurized liquid extraction and liquid chromatography–tandem mass spectrometry. Food Chem.116(4),1005–1012 (2009).
- 5 Lu Y, Zheng T, Dai Z et al. Rapid determination of chloramphenicol in soft-shelled turtle tissues using online MSPD-HPLC–MS/MS. Food Chem.134(1),533–539 (2012).
- 6 US Food and Drug Administration, Guidance for Industry: Bioanalytical Method Validation. US Department of Health and Human Services, US FDA, Center for Drug Evaluation, Rockville, MD, USA (2001).
- 7 Viswanathan CT, Bansal S, Booth B et al. Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand-binding assays. AAPS J.9(1),E30–E42 (2007).
- 8 Zhou M. Regulated Bioanalytical Laboratories: Technical and Regulatory Aspects from Global Perspectives. John Wiley and Sons, 23 (2011).
- 9 Smith KM, Xu Y. Tissue sample preparation in bioanalytical assays. Bioanalysis4(6),741–749 (2012).
- 10 Barroso M, King K, Zhang X et al. Case studies of accurate measurement of small molecule drugs in various tissues: knowledge versus assumption. Presented at: ASMS Annual Conference. CO, USA, 1–5 June 2008.
- 11 Lipinski CA, Lombardo F, Dominy BF, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Del. Rev.46,3–26 (2001).
